Education
About Us
Working with TipRanks
Follow Us
Modalis Therapeutics Corporation (JP:4883)
:4883
RESEARCH TOOLSreports
Total Valuation
Modalis Therapeutics Corporation has a market cap or net worth of ¥6.54B. The enterprise value is ¥54.90B.
Market Cap¥6.54B
Enterprise Value¥54.90B
Share Statistics
Modalis Therapeutics Corporation has 76,928,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding76,928,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Modalis Therapeutics Corporation’s return on equity (ROE) is -0.37 and return on invested capital (ROIC) is -37.45%.
Return on Equity (ROE)-0.37
Return on Assets (ROA)-0.36
Return on Invested Capital (ROIC)-37.45%
Return on Capital Employed (ROCE)-0.37
Revenue Per Employee0.00
Profits Per Employee-94.14M
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Modalis Therapeutics Corporation is -3.57. Modalis Therapeutics Corporation’s PEG ratio is -0.01.
PE Ratio-3.57
PS Ratio0.00
PB Ratio3.32
Price to Fair Value1.33
Price to FCF-4.66
Price to Operating Cash Flow-5.14
PEG Ratio-0.01
Income Statement
In the last 12 months, Modalis Therapeutics Corporation had revenue of 0.00 and earned -1.32B in profits. Earnings per share was -28.57.
Revenue0.00
Gross Profit0.00
Operating Income-1.34B
Pretax Income-1.32B
Net Income-1.32B
EBITDA-2.15B
Earnings Per Share (EPS)-28.57
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Modalis Therapeutics Corporation pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.21
52-Week Price Change24.29%
50-Day Moving Average79.96
200-Day Moving Average98.81
Relative Strength Index (RSI)50.79
Average Volume (3m)7.40M
Important Dates
Modalis Therapeutics Corporation upcoming earnings date is Aug 1, 2025, Before Open (Confirmed).
Last Earnings DateMay 8, 2025
Next Earnings DateAug 1, 2025
Ex-Dividend Date―
Financial Position
Modalis Therapeutics Corporation as a current ratio of 30.83, with Debt / Equity ratio of 0.00%
Current Ratio30.83
Quick Ratio30.83
Debt to Market Cap0.00
Net Debt to EBITDA1.67
Interest Coverage Ratio-146.02
Taxes
In the past 12 months, Modalis Therapeutics Corporation has paid 965.00K in taxes.
Income Tax965.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Modalis Therapeutics Corporation EV to EBITDA ratio is -0.53, with an EV/FCF ratio of -0.79.
EV to Sales0.00
EV to EBITDA-0.53
EV to Free Cash Flow-0.79
EV to Operating Cash Flow-0.79
Balance Sheet
Modalis Therapeutics Corporation has ¥3.58B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of -¥3.58B billion.
Cash & Marketable Securities¥3.58B
Total Debt¥0.00
Net Cash-¥3.58B
Net Cash Per Share-¥46.48
Tangible Book Value Per Share¥76.92
Margins
Gross margin is -205.37%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-205.37%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Modalis Therapeutics Corporation is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast59.56%